Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | Aclaris Therapeutics, Inc. | Walker Neal
(Interim President and CEO) |
F | Common Stock | D | 3223 | $1.24 - $1.24 | $3,996 |
| 2024-03-01 | Aclaris Therapeutics, Inc. | Powell Andrew Ken...
(Director) |
P | Common Stock | A | 14500 | $1.23 - $1.25 | $17,955 |
| 2024-02-01 | Aclaris Therapeutics, Inc. | Monahan Joseph
(Chief Scientific Officer) |
F | Common Stock | D | 2583 | $1.20 - $1.20 | $3,099 |
| 2024-02-01 | Aclaris Therapeutics, Inc. | Loerop James
(Chief Business Officer) |
F | Common Stock | D | 6421 | $1.20 - $1.20 | $7,704 |
| 2024-01-01 | Aclaris Therapeutics, Inc. | Manion Douglas J.
(Pres and CEO) |
F | Common Stock | D | 9125 | $1.05 - $1.05 | $9,581 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |